Neogen reported $159.9M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Agilent USD 1.76B 49M Jun/2026
Bio-Rad Laboratories USD 517M 9.8M Jun/2026
Cerus USD 19.96M 4.29M Dec/2025
Danaher USD 4.35B 1.35B Jun/2026
Idexx Laboratories USD 196.93M 3.6M Jun/2026
Illumina USD 1.09B 329M Mar/2026
Integra LifeSciences USD 214.42M 22.39M Jun/2026
Neogen USD 159.9M 14.56M Dec/2025
OraSure Technologies USD 160.58M 16.38M Jun/2026
Pacific Biosciences Of California USD 61M 4.73M Jun/2026
Quidel USD 123.4M 17M Jun/2026
Rockwell Medical USD 12.48M 1.09M Jun/2025
STAAR Surgical USD 148.58M 16.72M Jun/2026
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Utah Medical Products USD 84.27M 2.09M Sep/2025
Zoetis USD 1.48B 465M Jun/2026